NCT06649123 Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer
| NCT ID | NCT06649123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Origin Sciences |
| Condition | Colorectal Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,600 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-04-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,600 participants in total. It began in 2024-11-01 with a primary completion date of 2026-04-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.
Eligibility Criteria
Inclusion Criteria: 1. Patients 18 years and over 2. Patients referred from primary care to the 'urgent suspected cancer' CRC pathway during the study period. 3. Patients who provide voluntary written informed consent to participate in the study. Exclusion Criteria: 1. Patients who are unable to undergo digital rectal examination (DRE). 2. Patients with peri-anal/anal symptoms that may limit DRE and proctoscopy examination and it would be clinically inappropriate to attempt to assess these patients. This may include conditions such as: * Patients who have undergone radiotherapy. * An acute or chronic anal fissure * Perianal haematoma * Acute thrombosed haemorrhoids * Post- operative anal stenosis * The presence of an obstructing anal/low rectal tumour or discomfort as a result of previous pelvic radiotherapy 3. Current pregnancy or suspicion of pregnancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06649123 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Colorectal Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06649123 currently recruiting?
Yes, NCT06649123 is actively recruiting participants. Contact the research team at jon.lacy-colson@sath.nhs.uk for enrollment information.
Where is the NCT06649123 trial being conducted?
This trial is being conducted at Telford, United Kingdom.
Who is sponsoring the NCT06649123 clinical trial?
NCT06649123 is sponsored by Origin Sciences. The trial plans to enroll 6,600 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.